A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

Clinical trial NCT03591666 · UNKNOWN

Trial details

NCT number: NCT03591666
Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Carcinoma Adenocarcinoma Recurrent Disease Distantly Metastatic Malignant Neoplasm

Start date: 2018-07-15
Primary completion: 2019-12-31
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.